Spyre Therapeutics, Inc.

SYRE · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$64,897$81,659$48,493$89,423
Short-Term Investments$421,301$444,921$516,327$513,665
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$18,406$12,252$4,948$5,386
Total Curr. Assets$504,604$538,832$569,768$608,474
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$10$10
Total NC Assets$0$0$10$10
Other Assets$0$0$0$0
Total Assets$504,604$538,832$569,778$608,484
Liabilities
Payables$7,457$3,712$3,689$666
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$38,817$79,347$66,989$53,394
Total Curr. Liab.$46,274$83,059$70,678$54,060
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$3,230$0$16,490$36,620
Total NC Liab.$3,230$0$16,490$36,620
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$49,504$83,059$87,168$90,680
Equity
Pref Stock$155,820$155,820$155,820$155,820
Common Stock$13$13$13$13
Retained Earnings-$1,065,105-$1,053,922-$1,017,205-$972,432
AOCI$791$454$682$180
Other Equity$1,363,581$1,353,408$1,343,300$1,334,223
Total Equity$455,100$455,773$482,610$517,804
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$504,604$538,832$569,778$608,484
Net Debt-$64,897-$81,659-$48,493-$89,423